GlassScriptPhysician profile
Joseph Dalton
NPI 1487638623
$724.37
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $112 · 2021: $56.48 · 2022: $303 · 2023: $21.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $21.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $21.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $123.41 | 2019 | |
| Novo Nordisk INC | $102.02 | 2022 | |
| Kci USA, INC. | $69.24 | 2020-2021 | |
| Misonix INC | $42.99 | 2019 | |
| Davol INC. | $34.32 | 2020-2023 | Phasix Mesh |
| Bioventus LLC | $32.32 | 2022 | |
| Hydrofera LLC | $29.55 | 2022 | |
| Abbott Laboratories | $27.83 | 2022 | |
| Coopersurgical, INC. | $26.76 | 2020 | |
| Heron Therapeutics, INC. | $25.39 | 2022 | |
| Smith+Nephew, INC. | $24.66 | 2022 | |
| Convatec INC. | $24.60 | 2022 | |
| Angiodynamics, INC. | $22.45 | 2019 | |
| Trevena, INC. | $20.81 | 2021 | |
| Medtronic, INC. | $20.53 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $18.22 | 2022 | |
| Teleflex LLC | $18.21 | 2022 | |
| Acell, INC. | $17.65 | 2019 | |
| Integra Lifesciences Corporation | $17.62 | 2020 | |
| Kerecis Limited | $13.67 | 2019 | |
| W. L. Gore & Associates, INC. | $12.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Dalton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.